跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aspilets - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Aspilets
Approved
STANDARD
Aspilets
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cba570c664cff5c1
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
cba570c664cff5c1
Drug Approval Philippines Name
Aspilets
Product Name
Aspilets
Registration Number
DR-2350
Brand Name
Aspilets
Generic Name
Aspirin
Dosage Form
Tablet
Dosage Strength
80 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
L.R. Imperial Incorporated
Issuance Date
29 March 2022
Expiry Date
25 May 2027
Pharmacologic Category
Antithrombotic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cba570c664cff5c1
Type
Standard
Back to Philippines FDA Approvals